Generated: December 16, 2017
DrugPatentWatch Database Preview
« Back to Dashboard
When do Diphen patents expire, and when can generic versions of Diphen launch?
Diphen is a drug marketed by Usl Pharma, Morton Grove, Alra, Anabolic, Barr, Elkins Sinn, Halsey, Heather, Hikma Intl Pharms, Impax Labs, Ivax Sub Teva Pharms, Lannett, Lederle, LNK, Mk Labs, Mutual Pharm, Newtron Pharms, Nexgen Pharma Inc, Perrigo, Pioneer Pharms, Purepac Pharm, Pvt Form, Roxane, Sandoz, Sun Pharm Industries, Superpharm, Teva, Valeant Pharm Intl, Vangard, Watson Labs, Whiteworth Town Plsn, Bundy, Cenci, Kv Pharm, Naska, Pharm Assoc, App Pharms, Bel Mar, Eurohlth Intl Sarl, Hospira, Lyphomed, Mylan Institutional, Watson Labs Teva, West-ward Pharms Int, Wyeth Ayerst, Alpharma Us Pharms, Cumberland Swan, Hi Tech Pharma, Abraxis Pharm, Fresenius Kabi Usa, Intl Medication, Able, Ani Pharms Inc, Ascot, Hikma Pharms, Inwood Labs, Mylan, Par Pharm, Parke Davis, R And S Pharma, and Scherer Rp. and is included in ninety-eight NDAs.
The generic ingredient in DIPHEN is phenytoin sodium. There are nineteen drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the phenytoin sodium profile page.
US Patents and Regulatory Information
|App Pharms||DIPHENHYDRAMINE HYDROCHLORIDE||diphenhydramine hydrochloride||INJECTABLE;INJECTION||040466-001||May 28, 2002||AP||RX||No||No||► Subscribe||► Subscribe||► Subscribe|
|Par Pharm||DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE||atropine sulfate; diphenoxylate hydrochloride||TABLET;ORAL||040357-001||May 2, 2000||AA||RX||No||No||► Subscribe||► Subscribe||► Subscribe|
|Sandoz||DIPHENHYDRAMINE HYDROCHLORIDE||diphenhydramine hydrochloride||CAPSULE;ORAL||080845-001||Approved Prior to Jan 1, 1982||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe|
|Pioneer Pharms||DIPHENHYDRAMINE HYDROCHLORIDE||diphenhydramine hydrochloride||CAPSULE;ORAL||088880-001||Dec 20, 1985||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe|
|Abraxis Pharm||DIPHENHYDRAMINE HYDROCHLORIDE PRESERVATIVE FREE||diphenhydramine hydrochloride||INJECTABLE;INJECTION||080586-002||Approved Prior to Jan 1, 1982||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe|
|Valeant Pharm Intl||DIPHENHYDRAMINE HYDROCHLORIDE||diphenhydramine hydrochloride||CAPSULE;ORAL||080592-001||Approved Prior to Jan 1, 1982||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe|
|Scherer Rp||DIPHENOXYLATE HYDROCHLORIDE W/ ATROPINE SULFATE||atropine sulfate; diphenoxylate hydrochloride||CAPSULE;ORAL||086440-001||Approved Prior to Jan 1, 1982||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe|
|Bundy||DIPHENHYDRAMINE HYDROCHLORIDE||diphenhydramine hydrochloride||ELIXIR;ORAL||083674-001||Approved Prior to Jan 1, 1982||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe|
|Superpharm||DIPHENHYDRAMINE HYDROCHLORIDE||diphenhydramine hydrochloride||CAPSULE;ORAL||089041-001||May 15, 1985||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe|
|Parke Davis||DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE||atropine sulfate; diphenoxylate hydrochloride||TABLET;ORAL||087131-001||Approved Prior to Jan 1, 1982||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
« Back to Dashboard
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.